Huaren Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huaren Pharmaceutical Co Ltd with three other
companies in this sector in China:
Porton Fine Chemicals Ltd
sales of 1.02 billion Chinese Renmimbi [US$150.93 million]
of which 85%
was Pharmaceutical R&D Production Service Cu),
Henan Lingrui Pharmaceutical Co., Ltd.
(1.07 billion Chinese Renmimbi [US$158.14 million]
of which 99%
was Health Care), and
Shandong Jincheng Pharmaceutical Co Ltd
(1.18 billion Chinese Renmimbi [US$174.16 million]
of which 100%
was Medicine Manufacturing).
During the year ended December of 2015, sales at
Huaren Pharmaceutical Co Ltd were 1.11 billion Chinese Renmimbi (US$163.47 million).
increase of 20.6%
versus 2014, when the company's sales were 916.76 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Huaren Pharmaceutical Co Ltd
(and since 2010, sales have increased a total of 227%).